Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
14.65
Dollar change
+0.85
Percentage change
6.16
%
IndexRUT P/E- EPS (ttm)-11.28 Insider Own0.53% Shs Outstand92.20M Perf Week-12.85%
Market Cap1.35B Forward P/E18.74 EPS next Y0.78 Insider Trans10.53% Shs Float91.91M Perf Month-16.24%
Enterprise Value2.41B PEG0.40 EPS next Q0.17 Inst Own103.43% Short Float9.61% Perf Quarter22.59%
Income-1.02B P/S0.49 EPS this Y54.26% Inst Trans-5.91% Short Ratio6.48 Perf Half Y102.35%
Sales2.76B P/B2.33 EPS next Y53.59% ROA-32.08% Short Interest8.83M Perf YTD-15.07%
Book/sh6.30 P/C10.31 EPS next 5Y47.15% ROE-98.13% 52W High18.67 -21.53% Perf Year-5.85%
Cash/sh1.42 P/FCF- EPS past 3/5Y- 3.94% ROIC-60.47% 52W Low3.97 269.02% Perf 3Y-
Dividend Est.- EV/EBITDA157.49 Sales past 3/5Y-4.10% 1.11% Gross Margin15.73% Volatility10.07% 7.46% Perf 5Y-
Dividend TTM- EV/Sales0.87 EPS Y/Y TTM-259.57% Oper. Margin-2.44% ATR (14)1.18 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.00 Sales Y/Y TTM-0.54% Profit Margin-36.90% RSI (14)39.08 Recom2.62
Dividend Gr. 3/5Y- - Current Ratio1.00 EPS Q/Q44.03% SMA20-11.69% Beta1.69 Target Price16.80
Payout- Debt/Eq2.04 Sales Q/Q3.91% SMA50-9.01% Rel Volume1.21 Prev Close13.80
Employees15500 LT Debt/Eq1.90 EarningsFeb 26 BMO SMA20050.73% Avg Volume1.36M Price14.65
IPOJun 16, 2023 Option/ShortYes / Yes EPS/Sales Surpr.-25.09% 8.51% Trades Volume1,651,619 Change6.16%
Date Action Analyst Rating Change Price Target Change
Jan-08-26Upgrade Truist Hold → Buy $22
Jan-06-26Upgrade Evercore ISI In-line → Outperform $25
Dec-15-25Upgrade Barclays Underweight → Equal Weight $15
Dec-11-25Upgrade Citigroup Neutral → Buy $21
Aug-04-25Upgrade Robert W. Baird Neutral → Outperform $9
May-02-25Initiated Truist Hold $7
Apr-10-25Downgrade Barclays Equal Weight → Underweight $6
Dec-11-24Downgrade Citigroup Buy → Neutral $30 → $23
Dec-06-24Downgrade Robert W. Baird Outperform → Neutral $28 → $25
Sep-25-24Downgrade Jefferies Buy → Hold $25 → $21
Feb-06-26 07:15AM
Feb-05-26 07:38PM
Feb-02-26 09:00AM
Jan-29-26 08:08AM
Jan-28-26 11:40AM
04:11PM Loading…
Jan-16-26 04:11PM
12:13PM
Jan-14-26 08:55AM
Jan-12-26 11:40AM
Jan-09-26 11:24AM
Jan-07-26 08:06AM
Jan-06-26 07:00AM
Dec-19-25 03:16PM
Dec-18-25 11:50AM
Dec-11-25 07:17PM
02:16PM Loading…
02:16PM
Dec-10-25 08:19PM
06:00PM
Dec-04-25 07:00AM
Nov-25-25 01:01PM
07:00AM
Nov-24-25 06:46PM
07:00AM
Nov-17-25 07:00AM
Nov-13-25 10:56PM
Nov-12-25 12:36AM
Nov-11-25 10:35PM
10:56AM
Nov-06-25 05:50PM
12:32AM
07:32PM Loading…
Nov-05-25 07:32PM
02:55PM
02:02PM
07:40AM
07:02AM
06:30AM
Nov-03-25 10:08PM
Oct-27-25 06:57PM
Oct-24-25 06:43PM
Oct-20-25 01:35PM
07:00AM
Oct-15-25 07:00AM
Oct-13-25 07:31AM
Oct-11-25 09:48AM
Oct-08-25 01:45PM
Oct-06-25 09:41AM
Oct-02-25 02:39PM
Sep-25-25 05:10PM
Sep-22-25 04:30PM
Sep-12-25 04:15PM
Sep-11-25 02:15PM
Sep-08-25 06:57PM
Sep-05-25 07:03PM
Sep-03-25 12:36PM
Aug-27-25 12:02AM
Aug-25-25 09:55AM
Aug-22-25 07:02PM
Aug-21-25 11:37PM
Aug-19-25 12:09AM
Aug-13-25 01:37AM
Aug-12-25 08:00AM
03:18AM
Aug-07-25 08:48PM
Aug-06-25 01:20PM
07:45AM
07:36AM
06:30AM
Aug-05-25 06:00PM
08:15AM
Aug-04-25 11:06PM
04:30PM
Jul-29-25 08:00AM
07:20AM
Jul-23-25 03:36PM
Jul-22-25 02:05PM
08:45AM
Jul-18-25 08:45AM
Jul-16-25 07:00AM
Jul-15-25 08:58AM
08:00AM
Jul-11-25 12:51PM
10:46AM
09:00AM
Jul-07-25 08:06AM
Jun-30-25 08:55AM
08:00AM
Jun-26-25 09:49AM
Jun-24-25 09:15AM
07:00AM
Jun-20-25 11:40AM
Jun-16-25 11:38PM
Jun-13-25 12:15PM
Jun-12-25 08:36AM
Jun-11-25 04:10PM
Jun-04-25 09:35AM
Jun-03-25 04:05PM
May-30-25 12:00AM
May-13-25 03:05AM
May-12-25 06:03PM
07:50AM
Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments. The Clinical Services segment provides services across the clinical pharmacology, clinical development, and other clinical service spectrum utilizing enabling services and technology through multiple delivery models. The Enabling Services segment provides technology solutions directly to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. The company was founded on January 31, 2023 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hanson James S.Former OfficerJan 20 '26Proposed Sale15.5727,736431,935Jan 20 03:30 PM
Parks RobertChief Accounting OfficerSep 15 '25Option Exercise0.0024,934026,384Sep 17 04:16 PM
Parks RobertChief Accounting OfficerSep 16 '25Sale9.957,33873,01319,046Sep 17 04:16 PM
Parks RobertOfficerSep 16 '25Proposed Sale9.957,33873,008Sep 16 03:24 PM
Parks RobertChief Accounting OfficerSep 08 '25Option Exercise0.002,04202,042Sep 10 04:36 PM
Parks RobertChief Accounting OfficerSep 09 '25Sale10.235926,0561,450Sep 10 04:36 PM
Hanson James S.General CounselSep 08 '25Option Exercise0.005,788020,769Sep 10 04:34 PM
Hanson James S.General CounselSep 09 '25Sale10.231,67717,15619,092Sep 10 04:34 PM
Morais Mark A.Chief Operating OfficerSep 08 '25Option Exercise0.007,156060,131Sep 10 04:32 PM
Morais Mark A.Chief Operating OfficerSep 09 '25Sale10.233,15532,27656,976Sep 10 04:32 PM
Mcconnell Jill G.Chief Financial OfficerSep 08 '25Option Exercise0.007,156061,926Sep 10 04:30 PM
Mcconnell Jill G.Chief Financial OfficerSep 09 '25Sale10.233,15632,28658,770Sep 10 04:30 PM
Morais Mark A.OfficerSep 09 '25Proposed Sale10.233,15532,273Sep 09 04:48 PM
Parks RobertOfficerSep 09 '25Proposed Sale10.235926,056Sep 09 04:44 PM
Hanson James S.OfficerSep 09 '25Proposed Sale10.231,67717,154Sep 09 04:44 PM
Mcconnell Jill G.OfficerSep 09 '25Proposed Sale10.233,15632,283Sep 09 04:40 PM
Russell Erin LDirectorSep 02 '25Buy10.159,854100,0189,854Sep 04 04:39 PM
Morais Mark A.Chief Operating OfficerAug 18 '25Option Exercise0.0011,312057,861Aug 20 05:25 PM
Morais Mark A.Chief Operating OfficerAug 19 '25Sale8.014,88639,13752,975Aug 20 05:25 PM
Mcconnell Jill G.Chief Financial OfficerAug 18 '25Option Exercise0.0011,312059,656Aug 20 05:23 PM
Mcconnell Jill G.Chief Financial OfficerAug 19 '25Sale8.014,88639,13754,770Aug 20 05:23 PM
Morais Mark A.OfficerAug 19 '25Proposed Sale8.014,88639,160Aug 19 03:22 PM
Mcconnell Jill G.OfficerAug 19 '25Proposed Sale8.014,88639,160Aug 19 03:14 PM
NEUPERT PETER MDirectorAug 08 '25Buy6.7930,000203,70065,632Aug 11 08:21 PM
NEUPERT PETER MDirectorAug 11 '25Buy6.2632,500203,45098,132Aug 11 08:21 PM
Morais Mark A.Chief Operating OfficerJun 02 '25Option Exercise0.0011,007049,679Jun 04 05:44 PM
Morais Mark A.Chief Operating OfficerJun 03 '25Sale4.173,13013,05246,549Jun 04 05:44 PM
Mcconnell Jill G.Chief Financial OfficerJun 02 '25Option Exercise0.0011,007051,474Jun 04 05:43 PM
Mcconnell Jill G.Chief Financial OfficerJun 03 '25Sale4.173,13013,05248,344Jun 04 05:43 PM
Hanson James S.General CounselJun 02 '25Option Exercise0.007,706017,172Jun 04 05:42 PM
Hanson James S.General CounselJun 03 '25Sale4.172,1919,13614,981Jun 04 05:42 PM
Mcconnell Jill G.OfficerJun 03 '25Proposed Sale4.173,13013,050Jun 03 03:25 PM
Morais Mark A.OfficerJun 03 '25Proposed Sale4.173,13013,050Jun 03 03:23 PM
Hanson James S.OfficerJun 03 '25Proposed Sale4.172,1919,135Jun 03 03:15 PM
Smith David RossDirectorMay 14 '25Option Exercise0.007,282011,729May 16 04:51 PM
Pesicka Edward ADirectorMay 14 '25Option Exercise0.007,282013,636May 16 04:49 PM
Ray AmritDirectorMay 14 '25Option Exercise0.007,282013,636May 16 04:47 PM
SANDERS MACHELLEDirectorMay 14 '25Option Exercise0.007,28207,282May 16 04:45 PM
NEUPERT PETER MChief Executive OfficerMay 14 '25Option Exercise0.007,282035,632May 16 04:42 PM
Hanson James S.General CounselMar 13 '25Option Exercise0.002,998010,473Mar 17 04:37 PM
Hanson James S.General CounselMar 14 '25Sale9.701,0079,7689,466Mar 17 04:37 PM
Morais Mark A.Chief Operating OfficerMar 13 '25Option Exercise0.004,283039,879Mar 17 04:35 PM
Morais Mark A.Chief Operating OfficerMar 14 '25Sale9.701,20711,70838,672Mar 17 04:35 PM
Mcconnell Jill G.Chief Financial OfficerMar 13 '25Option Exercise0.004,283041,677Mar 17 04:33 PM
Mcconnell Jill G.Chief Financial OfficerMar 14 '25Sale9.701,21011,73740,467Mar 17 04:33 PM
Morais Mark A.Chief Operating OfficerMar 12 '25Option Exercise0.00725035,799Mar 14 04:32 PM
Morais Mark A.Chief Operating OfficerMar 13 '25Sale9.932032,01635,596Mar 14 04:32 PM
Mcconnell Jill G.Chief Financial OfficerMar 12 '25Option Exercise0.00935037,655Mar 14 04:31 PM
Mcconnell Jill G.Chief Financial OfficerMar 13 '25Sale9.932612,59237,394Mar 14 04:31 PM
Hanson James S.OfficerMar 14 '25Proposed Sale9.701,0079,766Mar 14 03:40 PM
Morais Mark A.OfficerMar 14 '25Proposed Sale9.701,20711,705Mar 14 03:40 PM
Mcconnell Jill G.OfficerMar 14 '25Proposed Sale9.701,21011,735Mar 14 03:40 PM
Morais Mark A.Chief Operating OfficerMar 11 '25Option Exercise0.001,573035,573Mar 13 04:54 PM
Morais Mark A.Chief Operating OfficerMar 12 '25Sale9.984994,98035,074Mar 13 04:54 PM
Mcconnell Jill G.Chief Financial OfficerMar 11 '25Option Exercise0.002,028037,363Mar 13 04:53 PM
Mcconnell Jill G.Chief Financial OfficerMar 12 '25Sale9.986436,41736,720Mar 13 04:53 PM
Morais Mark A.OfficerMar 13 '25Proposed Sale9.932032,015Mar 13 03:18 PM
Mcconnell Jill G.OfficerMar 13 '25Proposed Sale9.932612,591Mar 13 03:15 PM
Morais Mark A.OfficerMar 12 '25Proposed Sale9.984994,980Mar 12 03:15 PM
Mcconnell Jill G.OfficerMar 12 '25Proposed Sale9.986436,417Mar 12 03:09 PM
ECKERT R ANDREWDirectorFeb 21 '25Option Exercise0.007,282013,636Feb 25 05:12 PM
Morais Mark A.Chief Operating OfficerFeb 11 '25Option Exercise0.001,210034,424Feb 13 05:30 PM
Morais Mark A.Chief Operating OfficerFeb 12 '25Sale14.674246,22034,000Feb 13 05:30 PM
Mcconnell Jill G.Chief Financial OfficerFeb 11 '25Option Exercise0.001,544035,875Feb 13 05:28 PM
Mcconnell Jill G.Chief Financial OfficerFeb 12 '25Sale14.675407,92235,335Feb 13 05:28 PM
Mcconnell Jill G.OfficerFeb 12 '25Proposed Sale14.675407,923Feb 12 03:18 PM
Morais Mark A.OfficerFeb 12 '25Proposed Sale14.674246,221Feb 12 03:15 PM
Mcconnell Jill G.Chief Financial OfficerFeb 10 '25Sale14.805788,55434,331Feb 11 04:44 PM
Morais Mark A.Chief Operating OfficerFeb 10 '25Sale14.8077311,44033,214Feb 11 04:42 PM
Morais Mark A.OfficerFeb 10 '25Proposed Sale14.8077311,440Feb 10 04:22 PM
Mcconnell Jill G.OfficerFeb 10 '25Proposed Sale14.805788,554Feb 10 04:07 PM
Last Close
Feb 06  •  04:00PM ET
343.11
Dollar change
+12.86
Percentage change
3.89
%
KAI Kadant, Inc daily Stock Chart
IndexRUT P/E39.67 EPS (ttm)8.65 Insider Own1.07% Shs Outstand11.78M Perf Week6.87%
Market Cap4.04B Forward P/E33.49 EPS next Y10.24 Insider Trans-2.52% Shs Float11.65M Perf Month15.85%
Enterprise Value4.18B PEG8.21 EPS next Q2.19 Inst Own114.72% Short Float11.78% Perf Quarter25.85%
Income101.98M P/S3.95 EPS this Y-10.60% Inst Trans-3.62% Short Ratio10.15 Perf Half Y5.36%
Sales1.02B P/B4.25 EPS next Y11.48% ROA6.75% Short Interest1.37M Perf YTD20.38%
Book/sh80.64 P/C31.84 EPS next 5Y4.08% ROE11.32% 52W High409.73 -16.26% Perf Year-7.33%
Cash/sh10.78 P/FCF27.70 EPS past 3/5Y9.55% 15.84% ROIC8.47% 52W Low244.87 40.12% Perf 3Y65.18%
Dividend Est.- EV/EBITDA20.66 Sales past 3/5Y10.23% 8.37% Gross Margin45.10% Volatility4.31% 3.69% Perf 5Y136.45%
Dividend TTM1.36 (0.40%) EV/Sales4.09 EPS Y/Y TTM-11.55% Oper. Margin14.94% ATR (14)11.94 Perf 10Y784.08%
Dividend Ex-DateJan 08, 2026 Quick Ratio1.60 Sales Y/Y TTM-0.96% Profit Margin9.96% RSI (14)68.49 Recom2.00
Dividend Gr. 3/5Y8.58% 6.83% Current Ratio2.45 EPS Q/Q-12.40% SMA206.07% Beta1.21 Target Price337.50
Payout13.50% Debt/Eq0.27 Sales Q/Q-0.02% SMA5013.09% Rel Volume1.56 Prev Close330.25
Employees3500 LT Debt/Eq0.27 EarningsOct 28 AMC SMA20011.16% Avg Volume135.16K Price343.11
IPONov 09, 1992 Option/ShortYes / Yes EPS/Sales Surpr.18.74% 4.14% Trades Volume210,759 Change3.89%
Date Action Analyst Rating Change Price Target Change
Jul-07-23Resumed William Blair Outperform
Feb-19-21Upgrade Barrington Research Mkt Perform → Outperform $175
May-28-20Downgrade Sidoti Buy → Neutral
May-28-20Downgrade Barrington Research Outperform → Mkt Perform
Mar-24-20Upgrade Sidoti Neutral → Buy $88
Feb-14-20Reiterated Barrington Research Outperform $107 → $105
Jan-07-20Initiated DA Davidson Neutral $105
Dec-11-18Upgrade Sidoti Neutral → Buy
Mar-01-18Resumed Barrington Research Outperform $110
May-31-17Reiterated Barrington Research Outperform $80 → $86
Feb-04-26 08:48AM
Jan-29-26 08:14AM
Jan-22-26 08:05AM
Dec-24-25 11:35PM
Dec-16-25 11:02PM
11:31PM Loading…
Dec-04-25 11:31PM
Dec-03-25 03:26PM
Dec-01-25 06:12AM
Nov-27-25 10:34PM
Nov-21-25 09:06AM
Nov-13-25 04:39PM
Nov-09-25 11:47PM
Nov-04-25 11:56AM
12:36AM
Oct-30-25 03:56PM
08:16PM Loading…
Oct-29-25 08:16PM
Oct-28-25 06:20PM
05:34PM
05:19PM
05:03PM
09:36AM
Oct-26-25 11:09PM
Oct-24-25 09:10AM
Oct-23-25 10:52AM
Oct-08-25 09:39AM
Oct-07-25 04:53PM
Sep-17-25 11:35PM
Sep-04-25 04:46PM
Aug-21-25 10:07AM
Aug-14-25 12:03AM
11:32PM Loading…
Aug-12-25 11:32PM
11:27PM
Jul-31-25 03:27AM
Jul-30-25 01:41PM
Jul-29-25 05:50PM
05:05PM
04:52PM
04:32PM
09:34AM
Jul-28-25 09:24AM
Jul-27-25 11:09PM
Jul-24-25 10:01AM
Jun-25-25 02:17AM
May-28-25 04:58PM
May-26-25 11:32PM
May-19-25 12:00AM
May-15-25 04:26PM
04:19PM
May-05-25 12:37AM
May-03-25 01:26AM
May-01-25 05:47AM
03:14AM
Apr-30-25 09:53PM
10:22AM
Apr-29-25 05:55PM
05:18PM
04:55PM
04:43PM
Apr-28-25 03:07AM
Apr-24-25 11:41AM
07:40AM
Apr-06-25 12:54AM
Apr-04-25 01:43PM
Apr-02-25 01:27PM
Mar-30-25 05:52PM
Mar-26-25 05:03AM
Mar-25-25 05:06AM
Mar-12-25 12:45PM
Mar-05-25 04:26PM
Feb-21-25 03:33PM
Feb-14-25 06:32AM
02:17AM
Feb-13-25 05:54PM
Feb-12-25 07:00PM
06:20PM
05:28PM
05:07PM
04:43PM
07:27AM
Feb-11-25 09:14AM
08:09AM
Feb-10-25 02:51PM
Feb-07-25 04:13PM
Jan-21-25 10:33AM
Jan-07-25 04:06AM
Jan-06-25 04:28PM
Jan-01-25 04:08AM
Dec-19-24 04:07AM
Dec-12-24 07:16AM
Dec-06-24 03:10AM
Nov-27-24 12:00PM
Nov-14-24 04:33PM
Oct-31-24 03:13AM
Oct-29-24 06:30PM
06:00PM
05:00PM
04:53PM
04:43PM
04:14PM
09:08AM
Kadant Inc. operates as a global supplier of critical components and engineered systems used in process industries worldwide. It operates through the following segments: Flow Control, Industrial Processing, and Material Handling. The Flow Control segment includes custom-engineered products, systems, and technologies that control the flow of fluids used in industrial and commercial applications to keep critical processes running efficiently in the packaging, tissue, food, metals, and other industrial sectors. The Industrial Processing segment provides equipment, machinery, and technologies used to recycle paper and paperboard and process timber for use in the packaging, tissue, wood products and alternative fuel industries, among others. The Material Handling segment focuses on the products and engineered systems used to handle bulk and discrete materials for secondary processing or transport in the aggregates, mining, food, and waste management industries, among others. The company was founded in November 1991 and is headquartered in Westford, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Russell Erin LDirectorNov 25 '25Sale282.361,435405,1803,066Nov 26 08:16 AM
Russell Erin LDirectorNov 25 '25Proposed Sale282.241,435405,019Nov 25 02:37 PM
O'Mara Rebecca MartinezDirectorNov 11 '25Proposed Sale266.72699186,437Nov 12 11:23 AM
O'Mara Rebecca MartinezDirectorNov 11 '25Sale266.91699186,5691,141Nov 12 08:34 AM
LEONARD THOMAS CDirectorAug 27 '25Sale338.41415140,4424,250Aug 28 08:36 AM
LEONARD THOMAS CDirectorAug 27 '25Proposed Sale338.10415140,310Aug 27 03:23 PM
Blanchard Thomas AndrewVice PresidentAug 18 '25Sale343.00714244,9021,188Aug 19 04:29 PM
Blanchard Thomas AndrewOfficerAug 18 '25Proposed Sale342.82714244,770Aug 18 05:32 PM
Flynn Peter J.Senior Vice PresidentJun 13 '25Sale320.001,500480,0002,619Jun 13 04:14 PM
Flynn Peter J.OfficerJun 13 '25Proposed Sale319.911,500479,868Jun 13 01:36 PM
Blanchard Thomas AndrewVice PresidentMar 19 '25Sale341.59325111,0181,902Mar 20 09:05 AM
Blanchard Thomas AndrewOfficerMar 19 '25Proposed Sale341.18325110,882Mar 19 05:30 PM
MCKENNEY MICHAEL JExecutive Vice President & CFOFeb 28 '25Sale370.588,0262,974,28710,939Mar 03 04:14 PM
MCKENNEY MICHAEL JOfficerFeb 28 '25Proposed Sale370.548,0262,973,956Feb 28 04:16 PM